Ingenus Pharmaceuticals

Ingenus Pharmaceuticals company information, Employees & Contact Information

Ingenus Pharmaceuticals is a privately owned and U.S. based company working to meet the ever-rising demand for generics in the marketplace. By building a unique portfolio of complex formulations, Ingenus is transforming untapped areas of the market rather than competing amongst the crowd. With a passion to innovate the industry through state-of-the-art research and development facilities, extensive manufacturing presence, a strongly diversified commercial portfolio, and a devoted team to bring our vision to fruition, Ingenus stands out amongst the pack. Whether describing our product portfolio, customer relationships or human capital, Ingenus keeps true to one philosophy; quality over quantity. With a curated collection of strategic partners as well as several locations around the world, Ingenus has built a global network of top-notch talent to make a difference...one product at a time.

Company Details

Employees
221
Founded
-
Address
4901 Vineland Road, Suite 260,switzerland
Phone
+1-877-748-1970
Email
in****@****nus.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Orlando, FL
Looking for a particular Ingenus Pharmaceuticals employee's phone or email?

Ingenus Pharmaceuticals Questions

News

Judge Tosses Ingenus Suit Over Leukemia Treatment Patent - Law360

Judge Tosses Ingenus Suit Over Leukemia Treatment Patent Law360

Delaware Judge Bars Ingenus From Reviving Cancer-Drug Patent - Bloomberg Law News

Delaware Judge Bars Ingenus From Reviving Cancer-Drug Patent Bloomberg Law News

Patent on Ingenus Pharma cancer-fighting injection is invalid, US judge finds - MLex

Patent on Ingenus Pharma cancer-fighting injection is invalid, US judge finds MLex

Ingenus, Not Leiutis, Can Press Cancer-Patent Suit, Judge Says - Bloomberg Law News

Ingenus, Not Leiutis, Can Press Cancer-Patent Suit, Judge Says Bloomberg Law News

Nexus Wins Patent Litigation for Injectable Cyclophosphamide, Paving Way for Generic - Business Wire

Nexus Wins Patent Litigation for Injectable Cyclophosphamide, Paving Way for Generic Business Wire

Dr Reddy's Labs to commercialize Ingenus Pharma cancer injection Cyclophosphamide in US - Medical Dialogues

Dr Reddy's Labs to commercialize Ingenus Pharma cancer injection Cyclophosphamide in US Medical Dialogues

Dr Reddy's signs in-licensing pact with Ingenus Pharmaceuticals for cancer treatment injection - The Economic Times

Dr Reddy's signs in-licensing pact with Ingenus Pharmaceuticals for cancer treatment injection The Economic Times

Dr. Reddy’s to market Delaware LLC Ingenus Pharma’s cancer drug in U.S. - The Hindu

Dr. Reddy’s to market Delaware LLC Ingenus Pharma’s cancer drug in U.S. The Hindu

Dr Reddy’s Lab Shares Trade Higher as Subsidiary Inks a Licence Agreement - Equitypandit

Dr Reddy’s Lab Shares Trade Higher as Subsidiary Inks a Licence Agreement Equitypandit

Ingenus, Leiutis Sue Nexus to Block Copies of Cancer Treatment - Bloomberg Law News

Ingenus, Leiutis Sue Nexus to Block Copies of Cancer Treatment Bloomberg Law News

Top Ingenus Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant